{"nct_id":"NCT00154323","title":"The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2003-01","start_date_type":null,"primary_completion_date":"2006-01","primary_completion_date_type":"ACTUAL","completion_date":"2006-01","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}